Research

Spirulina extract’s effects on seniors’ health

October 10, 2013 — by Jack Mazurak
AlgaeIndustryMagazine.com

Dr. Gailen Marshall displays immulina in its capsule form.

Dr. Gailen Marshall displays immulina in its capsule form.

Can spirulina, the blue-green algae rich in linoleic acids, B vitamins and a variety of minerals – and used for centuries across ancient cultures to promote better health – improve immune systems in today’s seniors?

A clinical trial still enrolling participants is under way, at the University of Mississippi Medical Center (UMMC) in the Division of Allergy and Immunology, to test the theory that it may.

The pilot study at UMMC aims to identify whether and how much of the spirulina extract immulina it takes to improve the immune response of adults 60 and older. Seniors stand a greater risk for complications from colds, flu and other common infections.

“As people age, their susceptibility to mortality from influenza increases,” said Dr. Gailen Marshall, professor and R. Faser Triplet Sr. M.D. Chair in Allergy and Immunology. “Even the flu vaccine becomes less effective for them.”

Immulina magnified

Immulina magnified

Similarly, people’s immune systems weaken with age. That’s why older people die from infections, including flu, pneumonia, West Nile virus and sepsis, more often than younger people.

“If we can improve people’s immune system response with immulina, they may respond more robustly to the vaccine, which would better prepare their bodies to fight off the actual, live flu virus,” Marshall said.

He plans to enroll 50 people into the study. He began taking volunteers in August and will accept more on a rolling basis.

Participants will receive an envelope of pills – either immulina or a placebo – to take four times daily. They will visit a UMMC clinic weekly for four weeks to fill out questionnaires and give saliva samples and two tablespoons of blood.

After researchers collect the remaining pills, participants will make two return visits two weeks apart. By analyzing blood and saliva samples taken during and after the immulina treatment, Marshall and his team will be able to tell to what level and how long the immune-boosting effects lasted.

For the pilot study, Marshall is working with the National Center for Natural Products Research at the University of Mississippi, which is supplying and preparing the immulina. “I’ve collaborated for a couple years with Dr. Larry Walker and Dr. David Pascoe,” Marshall said. “They’d been working with immulina for a while and have considered it for use in cancer patients.”

If the results show promise, Marshall will apply to the National Institutes of Health to fund an investigation of immulina’s abilities to boost the effectiveness of flu vaccines in seniors. “That study would also consider whether immulina’s effects are different based on gender and race,” he said.

The pilot represents a piece in a larger puzzle, too. Marshall aims to establish a center for integrative medicine at UMMC that will investigate, teach and practice proven treatments and methods from the world’s major medical systems.

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2015 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
A new $1 million relationship between Michigan State University and ExxonMobil will expand research in the fundamental science to advance algae-based fuels. Dr. David Kra...
Glass tubing manufacturer SCHOTT, and Algatechnologies Ltd. (Algatech), a commercial algae producer and one of the largest manufacturers of natural astaxanthin, have part...
Tel Aviv, Israel-based UniVerve Ltd. has begun scaling-up its technological process for algae cultivation. The oil, which can be extracted with off-the-shelf wet extracti...
The Chesapeake Bay Seed Capital Fund, located in College Park, Maryland, has invested $150,000 into Manta Biofuel LLC, a company that produces crude oil from algae at a c...
The Technical University of Munich (TUM) has built a one-of-a-kind technical facility for algae cultivation at the Ludwig Bölkow Campus in Ottobrunn, to the south of Muni...
The Symbiosis Center in Denmark is exploring the industrial potential of microalgae, reports EUobserver's Regional Focus magazine. Using CO2 and light to produce valuable...
Hannah Osborne writes in the International Business Times that algae has been genetically engineered to kill cancer cells without harming healthy cells. The algae nanopar...
Bloomberg reports that ANA Holdings Inc., Japan’s largest airline, plans to use a Euglena Co. biofuel made from algae. ANA will use a mix of about 10 percent of the algae...
Algae producers moving from pilot to commercial applications require quick adaptation to algae harvesting capacity of hundreds and even thousands of cubic meters per day....
Algatechnologies Ltd. has launched its AstaPure® 5% Natural Astaxanthin oleoresin, derived from Haematococcus pluvialis microalgae. This latest addition to the AstaPure f...
I’m an aquanaut teen. I was born in immersion in 2050 in an underwater farm called “Aequorea” off the coast of Rio de Janeiro. Bio-inspired, the farm draws its name from ...
Algae.Tec has announced that it has completed the commissioning and initial startup of an algae production plant to produce algae-based nutraceutical products. The plant ...